Artificial intelligence could be new blueprint for precision drug discovery
The Pharma Data
JULY 12, 2021
.” In the new study, Ghosh and colleagues replaced the first and last steps in preclinical drug discovery with two novel approaches developed within the UC San Diego Institute for Network Medicine (iNetMed), which unites several research disciplines to develop new solutions to advance life sciences and technology and enhance human health.
Let's personalize your content